February 1, 1997Journal of Neurology Neurosurgery & PsychiatryOpen Access

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

View Full Paper

Ask AI

Bookmark

Abstract

[123I]FP-CIT SPECT allows a significant discrimination between patients with Parkinson's disease and age matched controls with a one day protocol, which will be to great advantage in outpatient evaluations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Booij et al. (1997) studied this question.

synapsesocial.com/papers/69dabde64a1e15904c836015 https://doi.org/10.1136/jnnp.62.2.133

View Full Paper

Ask AI

Bookmark

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Abstract

Discussion

Cite This Study

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Abstract

Discussion

Cite This Study

Keep reading

Keep reading